Cancer Network posts 10-episode series titled “Around the Practice: ctDNA in Treatment Decisions and Monitoring” in which expert oncologists discuss current and future use of minimal residual disease (MRD) and circulating tumor DNA (ctDNA) in colorectal cancer.
